2023-2029 Global Human Diploid Cellular Rabies Vaccine Industry Research & Trends Analysis Report
According to the research report, the global market for Human Diploid Cellular Rabies Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Human Diploid Cellular Rabies Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Human Diploid Cellular Rabies Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, 0.5ml segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Human Diploid Cellular Rabies Vaccine include Chengdu Kanghua, Wyeth Laboratories, Beijing Kangtai Biology, Sanofi Pasteur SA, Merieux Institute and Kanghua Biology, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
This report aims to provide a comprehensive study of the global market for Human Diploid Cellular Rabies Vaccine. Key Takeaways and Highlights
(1) Global Human Diploid Cellular Rabies Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Human Diploid Cellular Rabies Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Human Diploid Cellular Rabies Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Human Diploid Cellular Rabies Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Human Diploid Cellular Rabies Vaccine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Human Diploid Cellular Rabies Vaccine, capacity, production and trends.
(7) Human Diploid Cellular Rabies Vaccine industry supply chain, upstream, midstream and downstream analysis.
Regional Breakdown: Analyzing Market Segments by Geography
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Segmenting by Type: Comprehensive Coverage and Analysis
0.5ml
1ml
Application-Based Segmentation: Unlocking Market Opportunities
Hospital
Clinic
In the Spotlight: A Closer Look at Market Players
Chengdu Kanghua
Wyeth Laboratories
Beijing Kangtai Biology
Sanofi Pasteur SA
Merieux Institute
Kanghua Biology
1 Market Overview
1.1 Human Diploid Cellular Rabies Vaccine Definition
1.2 Global Human Diploid Cellular Rabies Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
1.2.2 By Sales Volume, Global Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
1.2.3 Global Human Diploid Cellular Rabies Vaccine Price Trend, 2018-2029
1.3 China Human Diploid Cellular Rabies Vaccine Market Size and Forecast
1.3.1 By Revenue, China Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
1.3.2 By Sales Volume, China Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
1.3.3 China Human Diploid Cellular Rabies Vaccine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Human Diploid Cellular Rabies Vaccine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Human Diploid Cellular Rabies Vaccine Share in Global Market, 2018-2029
1.4.3 Human Diploid Cellular Rabies Vaccine Market Size: China VS Global, 2018-2029
1.5 Human Diploid Cellular Rabies Vaccine Market Dynamics
1.5.1 Human Diploid Cellular Rabies Vaccine Market Drivers
1.5.2 Human Diploid Cellular Rabies Vaccine Market Restraints
1.5.3 Human Diploid Cellular Rabies Vaccine Industry Trends
1.5.4 Human Diploid Cellular Rabies Vaccine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Human Diploid Cellular Rabies Vaccine Revenue by Company, 2018-2023
2.2 Global Human Diploid Cellular Rabies Vaccine Sales Volume by Company, 2018-2023
2.3 Global Human Diploid Cellular Rabies Vaccine Price by Company, 2018-2023
2.4 Global Human Diploid Cellular Rabies Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Human Diploid Cellular Rabies Vaccine Concentration Ratio
2.6 Global Human Diploid Cellular Rabies Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Human Diploid Cellular Rabies Vaccine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Human Diploid Cellular Rabies Vaccine Revenue by Company, 2018-2023
3.2 China Human Diploid Cellular Rabies Vaccine Sales Volume by Company, 2018-2023
3.3 China Human Diploid Cellular Rabies Vaccine Human Diploid Cellular Rabies Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Human Diploid Cellular Rabies Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Human Diploid Cellular Rabies Vaccine Domestic VS Export
3.6 China Market, Human Diploid Cellular Rabies Vaccine Import & Export
3.6.1 China Market, Human Diploid Cellular Rabies Vaccine Import & Export, 2018-2029
3.6.2 China Human Diploid Cellular Rabies Vaccine Import & Export Trends
3.6.3 Main Sources of China Human Diploid Cellular Rabies Vaccine Import
3.6.4 Export Destination of China Human Diploid Cellular Rabies Vaccine
4 Human Diploid Cellular Rabies Vaccine Production by Region
4.1 Global Human Diploid Cellular Rabies Vaccine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Human Diploid Cellular Rabies Vaccine Manufacturers
4.3 Global Major Manufacturers, Human Diploid Cellular Rabies Vaccine Capacity Expansion and Future Plans
4.4 Global Human Diploid Cellular Rabies Vaccine Capacity by Region
4.5 Global Human Diploid Cellular Rabies Vaccine Production by Region
4.5.1 Global Human Diploid Cellular Rabies Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Human Diploid Cellular Rabies Vaccine Production by Region, 2018-2023
4.5.3 Global Human Diploid Cellular Rabies Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Human Diploid Cellular Rabies Vaccine Industry Chain
5.2 Human Diploid Cellular Rabies Vaccine Upstream Analysis
5.2.1 Human Diploid Cellular Rabies Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Human Diploid Cellular Rabies Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Human Diploid Cellular Rabies Vaccine Production Mode
5.6 Human Diploid Cellular Rabies Vaccine Procurement Model
5.7 Human Diploid Cellular Rabies Vaccine Industry Sales Model and Sales Channels
5.7.1 Human Diploid Cellular Rabies Vaccine Sales Model
5.7.2 Human Diploid Cellular Rabies Vaccine Typical Distributors
6 Sights by Type
6.1 Human Diploid Cellular Rabies Vaccine Classification
6.1.1 0.5ml
6.1.2 1ml
6.2 By Type, Global Human Diploid Cellular Rabies Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029
6.4 By Type, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029
6.5 By Type, Global Human Diploid Cellular Rabies Vaccine Price, 2018-2029
7 Sights by Application
7.1 Human Diploid Cellular Rabies Vaccine Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Human Diploid Cellular Rabies Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029
7.4 By Application, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029
7.5 By Application, Global Human Diploid Cellular Rabies Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Human Diploid Cellular Rabies Vaccine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029
8.3 By Region, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Human Diploid Cellular Rabies Vaccine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Human Diploid Cellular Rabies Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Human Diploid Cellular Rabies Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Human Diploid Cellular Rabies Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Human Diploid Cellular Rabies Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Human Diploid Cellular Rabies Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Human Diploid Cellular Rabies Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Human Diploid Cellular Rabies Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Human Diploid Cellular Rabies Vaccine Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029
9.3 By Country, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.4.2 By Company, U.S. Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.5.2 By Company, Europe Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.5.3 By Type, Europe Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.6.2 By Company, China Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.6.3 By Type, China Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.7.2 By Company, Japan Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.7.3 By Type, Japan Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.8.2 By Company, South Korea Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.10.2 By Company, India Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.10.3 By Type, India Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Human Diploid Cellular Rabies Vaccine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Human Diploid Cellular Rabies Vaccine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Chengdu Kanghua
10.1.1 Chengdu Kanghua Company Information, Head Office, Market Area and Industry Position
10.1.2 Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
10.1.3 Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Chengdu Kanghua Company Profile and Main Business
10.1.5 Chengdu Kanghua Recent Developments
10.2 Wyeth Laboratories
10.2.1 Wyeth Laboratories Company Information, Head Office, Market Area and Industry Position
10.2.2 Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
10.2.3 Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Wyeth Laboratories Company Profile and Main Business
10.2.5 Wyeth Laboratories Recent Developments
10.3 Beijing Kangtai Biology
10.3.1 Beijing Kangtai Biology Company Information, Head Office, Market Area and Industry Position
10.3.2 Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
10.3.3 Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Beijing Kangtai Biology Company Profile and Main Business
10.3.5 Beijing Kangtai Biology Recent Developments
10.4 Sanofi Pasteur SA
10.4.1 Sanofi Pasteur SA Company Information, Head Office, Market Area and Industry Position
10.4.2 Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
10.4.3 Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sanofi Pasteur SA Company Profile and Main Business
10.4.5 Sanofi Pasteur SA Recent Developments
10.5 Merieux Institute
10.5.1 Merieux Institute Company Information, Head Office, Market Area and Industry Position
10.5.2 Merieux Institute Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
10.5.3 Merieux Institute Human Diploid Cellular Rabies Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Merieux Institute Company Profile and Main Business
10.5.5 Merieux Institute Recent Developments
10.6 Kanghua Biology
10.6.1 Kanghua Biology Company Information, Head Office, Market Area and Industry Position
10.6.2 Kanghua Biology Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
10.6.3 Kanghua Biology Human Diploid Cellular Rabies Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Kanghua Biology Company Profile and Main Business
10.6.5 Kanghua Biology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Human Diploid Cellular Rabies Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Diploid Cellular Rabies Vaccine Market Restraints
Table 3. Human Diploid Cellular Rabies Vaccine Market Trends
Table 4. Human Diploid Cellular Rabies Vaccine Industry Policy
Table 5. Global Human Diploid Cellular Rabies Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Human Diploid Cellular Rabies Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Human Diploid Cellular Rabies Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Human Diploid Cellular Rabies Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Human Diploid Cellular Rabies Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Human Diploid Cellular Rabies Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Human Diploid Cellular Rabies Vaccine Manufacturers Product Type
Table 13. China Human Diploid Cellular Rabies Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Human Diploid Cellular Rabies Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Human Diploid Cellular Rabies Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Human Diploid Cellular Rabies Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Human Diploid Cellular Rabies Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Human Diploid Cellular Rabies Vaccine Import & Export Trends
Table 19. Main Sources of China Human Diploid Cellular Rabies Vaccine Import
Table 20. Export Destination of China Human Diploid Cellular Rabies Vaccine
Table 21. Global Headquarters and Manufacturing Base of Human Diploid Cellular Rabies Vaccine Manufacturers
Table 22. Global Major Manufacturers, Human Diploid Cellular Rabies Vaccine Capacity Expansion and Future Plans
Table 23. Global Human Diploid Cellular Rabies Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Human Diploid Cellular Rabies Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Human Diploid Cellular Rabies Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Human Diploid Cellular Rabies Vaccine Upstream (Raw Materials)
Table 27. Global Human Diploid Cellular Rabies Vaccine Typical Customers
Table 28. Human Diploid Cellular Rabies Vaccine Typical Distributors
Table 29. By Type, Global Human Diploid Cellular Rabies Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Human Diploid Cellular Rabies Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Human Diploid Cellular Rabies Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Human Diploid Cellular Rabies Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2018-2029
Table 39. Chengdu Kanghua Company Information, Head Office, Market Area and Industry Position
Table 40. Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
Table 41. Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Chengdu Kanghua Company Profile and Main Business
Table 43. Chengdu Kanghua Recent Developments
Table 44. Wyeth Laboratories Company Information, Head Office, Market Area and Industry Position
Table 45. Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
Table 46. Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Wyeth Laboratories Company Profile and Main Business
Table 48. Wyeth Laboratories Recent Developments
Table 49. Beijing Kangtai Biology Company Information, Head Office, Market Area and Industry Position
Table 50. Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
Table 51. Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Beijing Kangtai Biology Company Profile and Main Business
Table 53. Beijing Kangtai Biology Recent Developments
Table 54. Sanofi Pasteur SA Company Information, Head Office, Market Area and Industry Position
Table 55. Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
Table 56. Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sanofi Pasteur SA Company Profile and Main Business
Table 58. Sanofi Pasteur SA Recent Developments
Table 59. Merieux Institute Company Information, Head Office, Market Area and Industry Position
Table 60. Merieux Institute Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
Table 61. Merieux Institute Human Diploid Cellular Rabies Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Merieux Institute Company Profile and Main Business
Table 63. Merieux Institute Recent Developments
Table 64. Kanghua Biology Company Information, Head Office, Market Area and Industry Position
Table 65. Kanghua Biology Human Diploid Cellular Rabies Vaccine Models, Specifications and Application
Table 66. Kanghua Biology Human Diploid Cellular Rabies Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Kanghua Biology Company Profile and Main Business
Table 68. Kanghua Biology Recent Developments
List of Figure Figure 1. Human Diploid Cellular Rabies Vaccine Picture Figure 2. By Revenue, Global Human Diploid Cellular Rabies Vaccine Market Size and Forecast, 2018-2029, US$ Million Figure 3. By Sales Volume, Global Human Diploid Cellular Rabies Vaccine Market Size and Forecast, 2018-2029, (K Units) Figure 4. Global Human Diploid Cellular Rabies Vaccine Price Trend, 2018-2029, (US$/Unit) Figure 5. By Revenue, China Human Diploid Cellular Rabies Vaccine Market Size and Forecast, 2018-2029, US$ million Figure 6. By Sales Volume, China Human Diploid Cellular Rabies Vaccine Market Size and Forecast, 2018-2029, (K Units) Figure 7. China Human Diploid Cellular Rabies Vaccine Price Trend, 2018-2029 (US$/Unit) Figure 8. By Revenue, China Human Diploid Cellular Rabies Vaccine Share of Global Market, 2018-2029 Figure 9. By Sales Volume, China Human Diploid Cellular Rabies Vaccine Share of Global Market, 2018-2029 Figure 10. Global Human Diploid Cellular Rabies Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023 Figure 11. Global Human Diploid Cellular Rabies Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022 Figure 12. China Human Diploid Cellular Rabies Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023 Figure 13. China Human Diploid Cellular Rabies Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023 Figure 14. China Human Diploid Cellular Rabies Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023 Figure 15. Chinese Local Players, Proportion of Human Diploid Cellular Rabies Vaccine Domestic VS Export, 2022 Figure 16. Global Human Diploid Cellular Rabies Vaccine Capacity, Production and Capacity Utilization, 2018-2029 Figure 17. Global Human Diploid Cellular Rabies Vaccine Capacity Market Share by Region, 2022 VS 2029 Figure 18. Global Human Diploid Cellular Rabies Vaccine Production Market Share & Forecast by Region, 2018-2029 Figure 19. Human Diploid Cellular Rabies Vaccine Industry Chain Figure 20. Human Diploid Cellular Rabies Vaccine Procurement Model Figure 21. Human Diploid Cellular Rabies Vaccine Sales Model Figure 22. Human Diploid Cellular Rabies Vaccine Sales Channels, Direct Sales and Distribution Figure 23. 0.5ml Figure 24. 1ml Figure 25. By Type, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029, US$ Million Figure 26. By Type, Global Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2018-2029 Figure 27. By Type, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 28. By Type, Global Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2018-2029 Figure 29. By Type, Global Human Diploid Cellular Rabies Vaccine Price, 2018-2029, (US$/Unit) Figure 30. Hospital Figure 31. Clinic Figure 32. By Application, Global Human Diploid Cellular Rabies Vaccine Revenue, 2018-2029, US$ Million Figure 33. By Application, Global Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2018-2029 Figure 34. By Application, Global Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 35. By Application, Global Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2018-2029 Figure 36. By Application, Global Human Diploid Cellular Rabies Vaccine Price, 2018-2029, (US$/Unit) Figure 37. By Region, Global Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2018-2029 Figure 38. By Region, Global Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2018-2029 Figure 39. North America Human Diploid Cellular Rabies Vaccine Revenue & Forecasts, 2018-2029, US$ Million Figure 40. By Country, North America Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2022 Figure 41. Europe Human Diploid Cellular Rabies Vaccine Revenue & Forecasts, 2018-2029, US$ Million Figure 42. By Country, Europe Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2022 Figure 43. Asia Pacific Human Diploid Cellular Rabies Vaccine Revenue & Forecasts, 2018-2029, US$ Million Figure 44. By Country/Region, Asia Pacific Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2022 Figure 45. South America Human Diploid Cellular Rabies Vaccine Revenue & Forecasts, 2018-2029, US$ Million Figure 46. By Country, South America Human Diploid Cellular Rabies Vaccine Revenue Market Share, 2022 Figure 47. Middle East & Africa Human Diploid Cellular Rabies Vaccine Revenue & Forecasts, 2018-2029, US$ Million Figure 48. U.S. Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 49. By Company, U.S. Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 50. By Type, U.S. Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 51. By Application, U.S. Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 52. Europe Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 53. By Company, Europe Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 54. By Type, Europe Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 55. By Application, Europe Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 56. China Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 57. By Company, China Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 58. By Type, China Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 59. By Application, China Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 60. Japan Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 61. By Company, Japan Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 62. By Type, Japan Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 63. By Application, Japan Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 64. South Korea Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 65. By Company, South Korea Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 66. By Type, South Korea Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 67. By Application, South Korea Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 68. Southeast Asia Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 69. By Company, Southeast Asia Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 70. By Type, Southeast Asia Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 71. By Application, Southeast Asia Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 72. India Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 73. By Company, India Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 74. By Type, India Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 75. By Application, India Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 76. Middle East & Asia Human Diploid Cellular Rabies Vaccine Sales Volume, 2018-2029, (K Units) Figure 77. By Company, Middle East & Asia Human Diploid Cellular Rabies Vaccine Market Share, 2022 Figure 78. By Type, Middle East & Asia Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 79. By Application, Middle East & Asia Human Diploid Cellular Rabies Vaccine Sales Volume Market Share, 2022 VS 2029 Figure 80. Research Methodology Figure 81. Breakdown of Primary Interviews Figure 82. Bottom-up Approaches Figure 83. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|